Ah-Ng Tony Kong, PhD

Distinguished Professor, Glaxo Endowed Chair in Pharmaceutics; Graduate Director

Pharmaceutics

Grants/Funding

Dr. Kong is currently funded by NIH R01CA200129, R01AT007065 and R01AT009152.

Education & Training

PhD - Pharmaceutics, Pharmacokinetics and Pharmacodynamics - State University of New York, Buffalo, NY
BS - Pharmacy with First Class Standing - University of Alberta, Canada
Post-Doctoral Fellowship - Molecular Biology of Phase I/Phase II Drug Metabolizing Enzymes - National Institutes of Health
Post-Doctoral Fellowship - Cellular and Molecular Signaling of T-cell Activation - National Institutes of Health

Research Interests

Natural & Botanical Products Drug Discovery & Development, Epigenetics/epigenomics of oxidative stress/inflammation induced diseases including cancer and their prevention/treatment with botanicals/phytochemicals/drugs, Nrf2-mediated anti-oxidative stress/inflammation, Pharmacokinetics (PK)/pharmacodynamics (PD) studies and modeling. Dr. Kong’s current research focuses on, 1) Studies of botanical/dietary/herbal medicinal phytochemicals-mediated epigenetics/epigenomics signaling and diseases prevention such as cancer chemoprevention, 2) Nrf2-mediated redox signaling in anti-oxidative stress, anti-inflammatory, and Phase II drug metabolizing enzymes (DME) /Phase III transporters, 3) Pharmacokinetics (PK)/ pharmacodynamics (PD) studies and PKPD modeling of botanicals/dietary phytochemicals/drugs. Dr. Kong is currently funded by NIH R01CA200129, and R01AT009152.

Scholarly Activities

- Member, President’s Committee on Academic Program (CAPR)
- Director of the Graduate Program in Pharmaceutical Sciences
- Founding Editor-in-Chief, Current Pharmacology Reports (Springer)
- Serving on NIH study section panels

Publications

Awards

2018 - Clarivate Analytics (formerly Thomson Reuters) Highly Cited Researcher - among an elite group recognized for exceptional research performance demonstrated by production of multiple highly cited papers that rank in the top 1% by citations for field and year in Web of Science.
2018 – Overseas Visiting Professor, Khon Kaen University, Khon Kaen, Thailand.
2016 - Fellow (Elected), American Association for the Advancement of Science (AAAS)
2014 - Thomson Reuters Highly Cited Researcher – in recognition of ranking among the top 1% of researchers for most cited documents, in Pharmacology and Toxicology
2013 - Visiting Professor, Guangzhou University of Chinese Medicine, Guangzhou, China
2012 - Visiting Professor, Southern Medical University, Guangzhou, China
2011 - Guest Professor, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China
2009-2013 - Elected Member-at-Large, American Association for the Advancement of Science (AAAS)
2004 - Fellow (Elected), American Association of Pharmaceutical Scientists (AAPS)
2003 - Alumni Association Distinguished Visitor” under the Alumni Association Rotating Visiting Professorship Program, The King Edward VII College of Medicine and The Faculties of Medicine, Universities of Malaya and Singapore
1998 - Recognized by the American Association of Colleges of Pharmacy as Teacher of the Year
1998 - “Outstanding Teacher of the Year Award” from the first professional year class, University of Illinois at Chicago College of Pharmacy
1996 - “Outstanding Teacher of the Year Award” from the first professional year class, University of Illinois at Chicago College of Pharmacy
1994 - Young Investigator Award in Pharmacokinetics, Pharmacodynamics and Drug Metabolism from the American Association of Pharmaceutical Scientists (AAPS), Sponsored by Burroughs Wellcome Fund